Global Drug Abuse Treatment Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15083430 | Publishing Date : 14-Jan-2020 | No. of pages : 99
Factors such as frequent product launches, approval and robust pipeline of novel biopharmaceutical products, growing patient awareness, higher treatment seeking rate, growing government recognition and intervention of the issue, as well as encouragement to curb substance abuse in all countries are driving the growth of drug abuse treatment market globally.
Market Analysis and Insights: Global Drug Abuse Treatment Market
In 2019, the global Drug Abuse Treatment market size was US$ 16570 million and it is expected to reach US$ 26050 million by the end of 2026, with a CAGR of 6.6% during 2021-2026.
Global Drug Abuse Treatment Scope and Market Size
Drug Abuse Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Abuse Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Drug Abuse Treatment market is segmented into Opioid Addiction, Tobacco/Nicotine Addiction, Alcohol Dependence, etc.
Segment by Application, the Drug Abuse Treatment market is segmented into Hospital & Clinics, Residential (non-hospital), etc.
Regional and Country-level Analysis
The Drug Abuse Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug Abuse Treatment market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscapeand Drug Abuse Treatment Market Share Analysis
Drug Abuse Treatment market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Drug Abuse Treatment business, the date to enter into the Drug Abuse Treatment market, Drug Abuse Treatment product introduction, recent developments, etc.
The major vendors include Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey), etc.
This report focuses on the global Drug Abuse Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Abuse Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Dr. Reddy's Laboratories
Market segment by Type, the product can be split into
Market segment by Application, split into
Hospital & Clinics
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Drug Abuse Treatment status, future forecast, growth opportunity, key market and key players.
To present the Drug Abuse Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Drug Abuse Treatment are as follows:
History Year: 2015-2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region